The researchers reported that their assay could detect women with defective double-stranded break repair pathways even when sequencing could not.
With tens of thousands of immune cell measurements for almost 500 individuals, researchers saw enhanced genetic influence over some adaptive immune traits.
The certification enables the company to offer its flow cytometry-based myeloid-derived suppressor cell assay for cancer patients.
At the American Association for Clinical Chemistry meeting, Theranos CEO Elizabeth Holmes said her company is working on third-party review and publications of the firm's technologies and tests.
Researchers working on the Human Functional Genomics Project have begun to unravel genetic relationships and variations in human immune response.
Thermo Fisher will become the exclusive distributor for a technology to be developed with Boston-based Cytonome.
IncellDx's investigational molecular assay used to quantify HPV E6/E7 mRNA in single cells has been optimized to run on Beckman Coulter's CytoFlex flow cytometry system.
By buying Clarient, NeoGenomics hopes to move closer to its goal of becoming America's top cancer genetic testing lab.
The company launched the BD FACSseq flow cytometer and BD Precise Assays for high-throughput single-cell gene-expression analysis studies at the ASHG annual meeting.
The firm is predicting a return to growth in its genotyping business later this year as it targets the single-cell analysis market with its eBioscience business.
Mary Beckerle has been removed as director of the Huntsman Cancer Institute in what one researcher refers to as a "coup," ScienceInsider reports.
Bill Gates tells the Telegraph that bioterrorism is a serious risk.
The March for Science is to take place tomorrow, and supporters are tapping their creative energies to create placards to carry.
CBS News reports that the White House Science Fair is to continue under President Donald Trump.